Skip to main content
Journal cover image

Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis.

Publication ,  Journal Article
Kammerman, J; Hahn, AD; Cadman, RV; Malkus, A; Mummy, D; Fain, SB
Published in: Magn Reson Med
October 2020

PURPOSE: The MR properties (chemical shifts and R2∗ decay rates) of dissolved-phase hyperpolarized (HP) 129 Xe are confounded by the large magnetic field inhomogeneity present in the lung. This work improves measurements of these properties using a model-based image reconstruction to characterize the R2∗ decay rates of dissolved-phase HP 129 Xe in healthy subjects and patients with idiopathic pulmonary fibrosis (IPF). METHODS: Whole-lung MRS and 3D radial MRI with four gradient echoes were performed after inhalation of HP 129 Xe in healthy subjects and patients with IPF. A model-based image reconstruction formulated as a regularized optimization problem was solved iteratively to measure regional signal intensity in the gas, barrier, and red blood cell (RBC) compartments, while simultaneously measuring their chemical shifts and R2∗ decay rates. RESULTS: The estimation of spectral properties reduced artifacts in images of HP 129 Xe in the gas, barrier, and RBC compartments and improved image SNR by over 20%. R2∗ decay rates of the RBC and barrier compartments were lower in patients with IPF compared to healthy subjects (P < 0.001 and P = 0.005, respectively) and correlated to DLCO (R = 0.71 and 0.64, respectively). Chemical shift of the RBC component measured with whole-lung spectroscopy was significantly different between IPF and normal subjects (P = 0.022). CONCLUSION: Estimates for R2∗ in both barrier and RBC dissolved-phase HP 129 Xe compartments using a regional signal model improved image quality for dissolved-phase images and provided additional biomarkers of lung injury in IPF.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Magn Reson Med

DOI

EISSN

1522-2594

Publication Date

October 2020

Volume

84

Issue

4

Start / End Page

1857 / 1867

Location

United States

Related Subject Headings

  • Xenon Isotopes
  • Nuclear Medicine & Medical Imaging
  • Magnetic Resonance Imaging
  • Lung Injury
  • Lung
  • Idiopathic Pulmonary Fibrosis
  • Humans
  • Biomarkers
  • 4003 Biomedical engineering
  • 0903 Biomedical Engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kammerman, J., Hahn, A. D., Cadman, R. V., Malkus, A., Mummy, D., & Fain, S. B. (2020). Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis. Magn Reson Med, 84(4), 1857–1867. https://doi.org/10.1002/mrm.28246
Kammerman, Jeff, Andrew D. Hahn, Robert V. Cadman, Annelise Malkus, David Mummy, and Sean B. Fain. “Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis.Magn Reson Med 84, no. 4 (October 2020): 1857–67. https://doi.org/10.1002/mrm.28246.
Kammerman J, Hahn AD, Cadman RV, Malkus A, Mummy D, Fain SB. Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis. Magn Reson Med. 2020 Oct;84(4):1857–67.
Kammerman, Jeff, et al. “Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis.Magn Reson Med, vol. 84, no. 4, Oct. 2020, pp. 1857–67. Pubmed, doi:10.1002/mrm.28246.
Kammerman J, Hahn AD, Cadman RV, Malkus A, Mummy D, Fain SB. Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis. Magn Reson Med. 2020 Oct;84(4):1857–1867.
Journal cover image

Published In

Magn Reson Med

DOI

EISSN

1522-2594

Publication Date

October 2020

Volume

84

Issue

4

Start / End Page

1857 / 1867

Location

United States

Related Subject Headings

  • Xenon Isotopes
  • Nuclear Medicine & Medical Imaging
  • Magnetic Resonance Imaging
  • Lung Injury
  • Lung
  • Idiopathic Pulmonary Fibrosis
  • Humans
  • Biomarkers
  • 4003 Biomedical engineering
  • 0903 Biomedical Engineering